Multiple roles for HIV broadly neutralizing antibodies.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
30 10 2019
Historique:
received: 16 09 2019
accepted: 11 10 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 5 9 2020
Statut: ppublish

Résumé

Potent broadly neutralizing antibodies may be used to treat or prevent HIV and to help guide HIV vaccine design.

Identifiants

pubmed: 31666399
pii: 11/516/eaaz2686
doi: 10.1126/scitranslmed.aaz2686
pmc: PMC7171597
mid: NIHMS1577790
pii:
doi:

Substances chimiques

AIDS Vaccines 0
Broadly Neutralizing Antibodies 0
HIV Antibodies 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI144371
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144462
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Nat Med. 2019 Apr;25(4):547-553
pubmed: 30936546
Cell Host Microbe. 2017 Aug 9;22(2):207-216
pubmed: 28799906
Immunol Rev. 2017 Jan;275(1):161-182
pubmed: 28133806
Cell Host Microbe. 2016 Mar 9;19(3):292-303
pubmed: 26922989
Nat Biotechnol. 2012 May 07;30(5):423-33
pubmed: 22565972
Immunol Rev. 2013 Jul;254(1):225-44
pubmed: 23772623
Curr Opin Virol. 2013 Jun;3(3):322-31
pubmed: 23806515
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):
pubmed: 28159875
Nat Immunol. 2018 Nov;19(11):1179-1188
pubmed: 30333615

Auteurs

Barton F Haynes (BF)

Departments of Medicine and Immunology, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. barton.haynes@duke.edu.

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

John R Mascola (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20014, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH